BioNTech SE Q3 2021 Earnings Call Transcript - Thomson StreetEvents

BioNTech SE Q3 2021 Earnings Call Transcript

BioNTech SE Q3 2021 Earnings Call Transcript - Thomson StreetEvents
BioNTech SE Q3 2021 Earnings Call Transcript
Published Nov 09, 2021
16 pages (11844 words) — Published Nov 09, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of BNTX.OQ earnings conference call or presentation 9-Nov-21 1:00pm GMT

  
Brief Excerpt:

...Operator Welcome to BioNTech Third Quarter 2021 Update Call. (Operator Instructions) I must advise you this call is being recorded today, Tuesday, the 9th of November 2021. And I would now like to hand the meeting over to the Vice President, Investor Relations and Strategy, Sylke Maas. Please go ahead. Sylke Maas ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
BioNTech SE
Ticker
BNTX.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Daniel Wendorff - ODDO BHF Corporate & Markets, Research Division - Analyst : My question would be, in general, related to vaccines eventually eligible for being booster shots against the new coronavirus. Is that something very likely only limited to the mRNA vaccines? Or do you see any kind of other vaccine class potentially could be eligible for booster shots potentially also just looking beyond the third dose, if it is necessary at one point in time to potentially have regular booster shots. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. NOVEMBER 09, 2021 / 1:00PM, BNTX.OQ - Q3 2021 BioNTech SE Earnings Call

Question: Daniel Wendorff - ODDO BHF Corporate & Markets, Research Division - Analyst : Yes. So in simple terms, will it be just mRNA vaccines being eligible for the booster shot? Or are there any new developments, other patients to other vaccines, which would also make them likely to be available booster shots.

Question: Arlinda Anna Lee - Canaccord Genuity Corp., Research Division - Analyst : I guess with your commitment to equitable access and certain price points during the pandemic, how do you think about pricing and access in terms of boosters, pricing for the children's doses that maybe 1/10 and 1/3 of the original adult dose and then potentially emerge out of the pandemic control?

Table Of Contents

BioNTech SE To Discuss on Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations Call Transcript – 2022-06-29 – US$ 54.00 – Edited Transcript of BNTX.OQ conference call or presentation 29-Jun-22 12:00pm GMT

BioNTech SE Q1 2022 Earnings Call Transcript – 2022-05-09 – US$ 54.00 – Edited Transcript of BNTX.OQ earnings conference call or presentation 9-May-22 12:00pm GMT

BioNTech SE Q4 2021 Earnings Call Transcript – 2022-03-30 – US$ 54.00 – Edited Transcript of BNTX.OQ earnings conference call or presentation 30-Mar-22 12:00pm GMT

BioNTech SE at JPMorgan Healthcare Conference Transcript – 2022-01-11 – US$ 54.00 – Edited Transcript of BNTX.OQ presentation 11-Jan-22 2:45pm GMT

BioNTech SE To Discuss Hold Digital Press Conference to Provide an Update on Omicron Variant Call Transcript – 2021-12-08 – US$ 54.00 – Edited Transcript of BNTX.OQ conference call or presentation 8-Dec-21 2:00pm GMT

BioNTech SE Q2 2021 Earnings Call Transcript – 2021-08-09 – US$ 54.00 – Edited Transcript of BNTX.OQ earnings conference call or presentation 9-Aug-21 12:00pm GMT

BioNTech SE at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-08 – US$ 54.00 – Edited Transcript of BNTX.OQ presentation 8-Jun-21 12:00pm GMT

BioNTech SE at Jefferies Healthcare Conference (Virtual) Transcript – 2021-06-01 – US$ 54.00 – Edited Transcript of BNTX.OQ presentation 1-Jun-21 3:00pm GMT

BioNTech SE at UBS Global Healthcare Virtual Conference Transcript – 2021-05-26 – US$ 54.00 – Edited Transcript of BNTX.OQ presentation 26-May-21 12:00pm GMT

BioNTech SE Q1 2021 Earnings Call Transcript – 2021-05-10 – US$ 54.00 – Edited Transcript of BNTX.OQ earnings conference call or presentation 10-May-21 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "BioNTech SE Q3 2021 Earnings Call Transcript" Nov 09, 2021. Alacra Store. May 13, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-BioNTech-SE-Earnings-Call-T14626754>
  
APA:
Thomson StreetEvents. (2021). BioNTech SE Q3 2021 Earnings Call Transcript Nov 09, 2021. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-BioNTech-SE-Earnings-Call-T14626754>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.